摘要
目的 :观察铋制剂、洛赛克、替硝唑治疗幽门螺杆菌 (Hp)阳性消化性溃疡的近期和远期疗效。方法 :将10 2例患者随机分为两组 ,治疗组 (5 2例 ) :丽珠得乐冲剂 1.0 g,1d4次 ;洛赛克 2 0 mg,替硝唑 0 .5 g,1d2次口服 ;疗程 2周。对照组 (5 0例 ) :洛赛克 2 0 mg,qd头孢羟氨苄 0 .5 g,1d4次 ;甲硝唑 40 0 mg,1d2次 ;疗程 2周。疗程结束后 2周行胃镜检查 ,病理检查及 Hp检测 ;并于半年 ,1年进行相应的随访 ,结果 :治疗组和对照组溃疡愈合率分别为 90 .38%和 88.0 0 % ,Hp根除率分别为 88.46 %和 86 .0 0 % ,两组比较无显著差异 (P >0 .0 5 )。治疗组疗程后半年、1年溃疡复发率为 2 .17%和 4.35 % ,Hp再发率为 4.35 %和 6 .5 2 % ;对照组疗程后半年、1年溃疡复发率为14.2 9%和 19.0 5 % ,Hp再发率为 19.0 5 %和 2 1.43%。两组比较有显著差异 (P <0 .0 5 )。铋制剂、洛赛克加替硝唑治疗 Hp阳性溃疡的远期疗效优于洛赛克加两种抗生素的疗效 ,差异显著 (P <0 .0 5 )。结论 :两种疗法近期疗效相似 ,但远期疗效治疗组优于对照组 (P >0 .0 5 )
Objective:To study the long term and short term effect of bismuth combined with losec,tinidazole on the patients with positive helicobacter pyolri(H.pylori)peptic ulcer.Methods:102 patients with positive H.pylori peptic ulcer were diagnosed by endoscopic examination and were randomized into two groups:treatment group(52 cases) received De Nol (1.0 g,qid),losec(20 mg,qd),tinidazole(0.5 g,bid)and control group(50 cases)losec(20 mg,qd)combined with amoxicillin(0.5,qid),metronidazole(400 mg,bid)for 2 weeks.Clinical,endoscopic,pathological and bacterioogical evaluations were made 1/2 months,6 months and 12 months respectively after the treatment.Results:Ulcer healing rates were 90.38% and 88.00% in treatment group and control group,respectively(P> 0.05 );eradication rates of H.pylori were 88.46% and 86.00% in treatment and control group,respectively(P> 0.05 );6 months,12 months after the treatment,recurrence rates of peptic ulcer in treatment gronp were significantly lower than those of control group,respectively(2.17% vs 14.29% and 4.35% vs 19.05%),and H.pylori reinfection rates in treatment group were also significantly lower than those of control group,respectively(4.35%vs 19.05% and 6.52% vs 21.43%)and P< 0.05 .Conclusions:The long term effect of bismuth,losec and tinidazole combination therapy(2 weeks)is better than that of losec combined with amoxicillin and metronidazole for H.pylori associated peptic ulcer.
关键词
幽门螺杆菌
消化性溃疡
铋制剂
洛赛克
替硝唑
Helicobacter pylori
Peptic ulcer
Bismuth preparation
Losec
Tinidazole